Philip Morris International (PMI) has announced that it is continuing preparations to submit a premarket tobacco product application (PMTA) to the US Food and Drug Administration (FDA) in the second half of next year for a new Iqos e-vapour device.
The manufacturer said during its third-quarter earnings presentation that the product was making “good progress” in the markets where it has been launched so far.
Get access to premium content that is normally only available for subscribers.
For the duration of a week, you can read our news analysis, identify market trends and understand upcoming changes in the industry, which will enable you to get ahead of your competitors.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
LATEST ALERTS
